Journal Article

Phase III Randomized Comparison of Postoperative Adjuvant Chemotherapy with 2-Year Oral UFT (Uracil/Tegafur) versus Six-Cycle CMF (Cyclophosphamide/Methotrexate/5-Fluorouracil) in High-risk Node-Negative Breast Cancer Patients

in Japanese Journal of Clinical Oncology

Volume 28, issue 1, pages 77-80
Published in print January 1998 | ISSN: 0368-2811
Published online January 1998 | e-ISSN: 1465-3621 | DOI: https://dx.doi.org/10.1093/jjco/28.1.77
Phase III Randomized Comparison of Postoperative Adjuvant Chemotherapy with 2-Year Oral UFT (Uracil/Tegafur) versus Six-Cycle CMF (Cyclophosphamide/Methotrexate/5-Fluorouracil) in High-risk Node-Negative Breast Cancer Patients

Show Summary Details

Journal Article.  1897 words.  Illustrated.

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.